Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Adma Biologics (ADMA)

Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Adma Biologics: Q4 Earnings Snapshot AP - Wed Feb 28, 4:30PM CST

Adma Biologics: Q4 Earnings Snapshot

ADMA : 6.20 (+2.65%)
Why Adma Biologics Stock Crushed the Market on Friday Motley Fool - Fri Nov 17, 2023

The network of FDA-approved collection facilities continues to grow.

ADMA : 6.20 (+2.65%)
Why Adma Biologics Was Trouncing the Market Today Motley Fool - Thu Nov 9, 2023

The company beat analyst estimates for both revenue and profitability, and raised revenue guidance.

ADMA : 6.20 (+2.65%)
Adma Biologics: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Adma Biologics: Q3 Earnings Snapshot

ADMA : 6.20 (+2.65%)
Why Shares of ADMA Biologics Are Climbing Thursday Motley Fool - Thu Aug 10, 2023

The company, which focuses on infectious diseases, reported its second-quarter earnings on Wednesday after the markets closed.

ADMA : 6.20 (+2.65%)
Adma Biologics: Q2 Earnings Snapshot AP - Wed Aug 9, 2023

Adma Biologics: Q2 Earnings Snapshot

ADMA : 6.20 (+2.65%)
Adma Biologics (ADMA) Reports Q1 Loss, Tops Revenue Estimates Zacks - Wed May 10, 2023

Adma Biologics (ADMA) delivered earnings and revenue surprises of 40% and 10.84%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ADMA : 6.20 (+2.65%)
SABS : 4.46 (-3.04%)
Adma Biologics: Q1 Earnings Snapshot AP - Wed May 10, 2023

Adma Biologics: Q1 Earnings Snapshot

ADMA : 6.20 (+2.65%)
Esperion (ESPR) Q1 Earnings Miss Estimates, Sales Beat, Stock Up Zacks - Wed May 10, 2023

Esperion (ESPR) reports mixed first-quarter 2023 results, wherein earnings miss and revenues beat estimates. The stock of the company surges 5% on Tuesday. The company maintains 2023 guidance.

ADMA : 6.20 (+2.65%)
ESPR : 1.8700 (+1.63%)
ANIX : 3.10 (+1.64%)
ALLO : 3.46 (-1.42%)
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates Zacks - Tue May 9, 2023

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -33.33% and 1.72%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BNGO : 0.7872 (-3.51%)
ADMA : 6.20 (+2.65%)

Barchart Exclusives

3 Energy Dividend Stocks Leading the S&P 500 Higher Barchart - Thu Apr 18, 6:30PM CDT
These three energy dividend stocks have outperformed the S&P 500 on a year-to-date basis, and rank among the index's top 20 performers of 2024 so far. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot